{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:16:13Z","timestamp":1760660173808,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":3517,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.rmed.2003.07.006","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T17:43:50Z","timestamp":1064252630000},"page":"1269-1276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy"],"prefix":"10.1016","volume":"97","author":[{"given":"D.C","family":"Malone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T","family":"Luskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2003.07.006_BIB1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1067\/mai.2000.109426","article-title":"Trends in the cost of illness for asthma in the United States, 1984\u20131994","volume":"106","author":"Weiss","year":"2000","journal-title":"J Aller Clin Immunol"},{"key":"10.1016\/j.rmed.2003.07.006_BIB2","unstructured":"National Heart Lung and Blood Institute. National Asthma Education Program Expert Panel Report 2: guidelines for the diagnosis and management of asthma. NIH Publication No. 97\u20134051, US Government Printing Office, Bethesda, MD."},{"key":"10.1016\/j.rmed.2003.07.006_BIB3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/00005650-199612000-00004","article-title":"Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden","volume":"34","author":"Gerdtham","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.rmed.2003.07.006_BIB4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00019053-200018030-00005","article-title":"Cost implications for the use of inhaled anti-inflammatory medications in the treatment of asthma","volume":"18","author":"Ozminkowski","year":"2000","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.rmed.2003.07.006_BIB5","first-page":"67","article-title":"A comparison of the cost-effectiveness of budesonide 400\u03bcg\/day and 800\u03bcg\/day in the management of mild-to-moderate asthma in general practice","volume":"6","author":"Campbell","year":"1993","journal-title":"Br J Med Econ"},{"key":"10.1016\/j.rmed.2003.07.006_BIB6","first-page":"127","article-title":"The cost-effectiveness of budesonide in severe asthmatics aged one to three years","volume":"6","author":"Connett","year":"1993","journal-title":"Br J Med Econ"},{"key":"10.1016\/j.rmed.2003.07.006_BIB7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00019053-199304040-00004","article-title":"Cost-effectiveness of inhaled corticosteroids plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma","volume":"4","author":"Rutten-van Molken","year":"1993","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.rmed.2003.07.006_BIB8","first-page":"975","article-title":"Costs and effects of inhaled corticosteroids and bronchodialtors in asthma and chronic obstructive pulmonary disease","volume":"151","author":"Rutten-van Molken","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2003.07.006_BIB9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/adc.72.4.312","article-title":"Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country","volume":"72","author":"Perera","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.rmed.2003.07.006_BIB10","first-page":"65","article-title":"Comparison of the cost effectiveness of alternative prophylactic therapies in the treatment of adult asthma","volume":"8","author":"Booth","year":"1995","journal-title":"Br J Med Econ"},{"key":"10.1016\/j.rmed.2003.07.006_BIB11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00044011-199816020-00004","article-title":"Cost effectiveness of fluticasone and budesonide in patients with moderate asthma","volume":"16","author":"Steinmetz","year":"1998","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.rmed.2003.07.006_BIB12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/rmed.1999.0577","article-title":"The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children","volume":"93","author":"Barnes","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2003.07.006_BIB13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/00019053-199916050-00008","article-title":"Cost-effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma","volume":"16","author":"Volmer","year":"1999","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.rmed.2003.07.006_BIB14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1081-1206(10)62905-5","article-title":"Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol","volume":"86","author":"Fireman","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmed.2003.07.006_BIB15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/ajrccm\/154.3_Pt_2.S84","article-title":"National Asthma Education and Prevention Program Working Group Report on cost-effectiveness of asthma care","volume":"154","author":"Sullivan","year":"1996","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.rmed.2003.07.006_BIB16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00019053-199304050-00005","article-title":"Episode-free day as a composite measure of effectiveness","volume":"4","author":"Sculpher","year":"1993","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.rmed.2003.07.006_BIB17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1099-1050(199607)5:4<297::AID-HEC216>3.0.CO;2-T","article-title":"Confidence intervals for cost-effectiveness ratios","volume":"5","author":"Willan","year":"1996","journal-title":"Health Econ"},{"key":"10.1016\/j.rmed.2003.07.006_BIB18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0091-6749(99)70016-3","article-title":"Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant","volume":"104","author":"Busse","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2003.07.006_BIB19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.115.2.343","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate, 400\u03bcg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800\u03bcg, for the treatment of moderate asthma","volume":"115","author":"Gross","year":"1999","journal-title":"Chest"},{"issue":"Suppl A","key":"10.1016\/j.rmed.2003.07.006_BIB20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0954-6111(98)90214-1","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose","volume":"92","author":"Davies","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2003.07.006_BIB21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/rmed.2000.1025","article-title":"Efficacy of HFA-beclomethasone dipropionate extrafine aerosol (800\u03bcg\/day) versus HFA-fluticasone (1000\u03bcg\/day) in patients with asthma","volume":"95","author":"Aubier","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2003.07.006_BIB22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1081-1206(10)62907-9","article-title":"A randomized double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate","volume":"86","author":"Fairfax","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmed.2003.07.006_BIB23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000050561","article-title":"Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control","volume":"68","author":"Worth","year":"2001","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2003.07.006_BIB24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1742-1241.2001.tb10990.x","article-title":"Extrafine beclomethasone dipropionate breath-actuated inhaler (400\u03bcg\/day) versus budesonide dry powder inhaler (800\u03bcg\/day) in asthma","volume":"55","author":"Reichel","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rmed.2003.07.006_BIB25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/ajrccm\/147.4.832","article-title":"Measuring quality of life in asthma","volume":"147","author":"Juniper","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmed.2003.07.006_BIB26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1067\/mai.2000.111582","article-title":"Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma","volume":"106","author":"Vanden Burgt","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.rmed.2003.07.006_BIB27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/rmed.1999.0577","article-title":"The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children","volume":"93","author":"Barnes","year":"1999","journal-title":"Respir Med"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611103002609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611103002609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:04:20Z","timestamp":1760609060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611103002609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0954611103002609"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2003.07.006","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2003.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}